JPMorgan Sees Double-Digit Sales Ahead For NuVasive, Upgrades To Overweight

By: via Benzinga
JPMorgan’s Andrew R. Hanover believes a “margin improvement story” is playing out at NuVasive, Inc. (NASDAQ: NUVA), ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.